- Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab
Carlo Putzu et al, 2018, Cancer Immunology, Immunotherapy CrossRef - Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
Sara S. Fois et al, 2021, International Journal of Molecular Sciences CrossRef - Long Noncoding RNAs in Non-Small Cell Lung Cancer: State of the Art
Panagiotis Paliogiannis et al, 2020, The Chemical Biology of Long Noncoding RNAs CrossRef - Genetic Instability Markers in Cancer
Giuseppe Palmieri et al, 2020, Biomarkers for Immunotherapy of Cancer CrossRef - Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
Maria Maddalena Simile et al, 2019, Medicina CrossRef - An Insight into Cholangiocarcinoma and Recent Advances in its Treatment
Rakesh Sahu et al, 2022, Journal of Gastrointestinal Cancer CrossRef - EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
null null et al, 2019, BMC Pulmonary Medicine CrossRef - Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study
Panagiotis Paliogiannis et al, 2022, BMC Pulmonary Medicine CrossRef